Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study

Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (Other)
Overall Status
Completed
CT.gov ID
NCT02464592
Collaborator
Hospital Universitario La Fe (Other), Germans Trias i Pujol Hospital (Other), Hospital General Universitario Santa Lucía (Other), Hospital Universitari de Bellvitge (Other), Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (Other), Complejo Hospitalario Universitario de Vigo (Other), University of Salamanca (Other), Hospital Universitario de Valladolid (Other)
120
1
2
40
3

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the diagnostic yield and safety of transbronchial lung biopsies (TBLB) with cryoprobe versus conventional forceps in patients with diffuse lung disease.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Transbronchial lung biopsy.
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study
Actual Study Start Date :
Apr 1, 2014
Actual Primary Completion Date :
Aug 1, 2017
Actual Study Completion Date :
Aug 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Biopsy with Cryoprobes

Transbronchial lung biopsy with a cryoprobe.

Procedure: Transbronchial lung biopsy.
Transbronchial lung biopsy with cryoprobe and with conventional forceps.

Active Comparator: Biopsy with Conventional Forceps

Transbronchial lung biopsy with conventional forceps.

Procedure: Transbronchial lung biopsy.
Transbronchial lung biopsy with cryoprobe and with conventional forceps.

Outcome Measures

Primary Outcome Measures

  1. Diagnostic yield of transbronchial lung biopsy (TBLB) [24 months]

    Comparing those TBLB obtained by cryoprobes versus conventional forceps (number of diagnosis with each technique).

Secondary Outcome Measures

  1. Histological quality of samples as defined the presence of alveolar units in each sample. Composite measure. [24 months]

    The quality of samples are defined by the size, presence of artifacts and presence of alveolar units in each sample.

  2. Safety related to the procedure of the TBLB obtained by cryoprobe compared with conventional forceps assessed by chest radiography. [24 months]

    Chest radiography after TBLB.

  3. Safety related to the procedure of the TBLB obtained by cryoprobe compared with conventional forceps assessed by control of bleeding. [24 months]

    Control of bleeding during procedure.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years old

  • Patients with diffuse lung disease candidate to study with transbronchial lung biopsy (TBLB).

  • Inform consent signed.

Exclusion Criteria:
  • FEV1 <40% of reference value.

  • Respiratory insufficiency (pO2 <60 mmHg or pCO2 >45 mmHg).

  • Use of anticoagulant therapy or presence of a coagulation (disorder abnormal platelets counts, international normalized ratio > 1.5).

  • Bullous emphysema.

  • Pulmonary arterial hypertension.

  • Hypersensitivity to anaesthetic and sedative drugs (lidocaine, midazolam, propofol, remifentanyl).

  • Psychiatric illness.

  • Comorbidities that could increase the risk of the TBLB.

  • Pregnancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital de la Santa Creu i Sant Pau Barcelona Spain 08025

Sponsors and Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
  • Hospital Universitario La Fe
  • Germans Trias i Pujol Hospital
  • Hospital General Universitario Santa Lucía
  • Hospital Universitari de Bellvitge
  • Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
  • Complejo Hospitalario Universitario de Vigo
  • University of Salamanca
  • Hospital Universitario de Valladolid

Investigators

  • Principal Investigator: Virginia Pajares, PhD, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
ClinicalTrials.gov Identifier:
NCT02464592
Other Study ID Numbers:
  • IIBSP-CRI-2014-05
First Posted:
Jun 8, 2015
Last Update Posted:
Sep 29, 2017
Last Verified:
Sep 1, 2017
Keywords provided by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 29, 2017